Na,K-ATPase alpha isoforms at the blood-cerebrospinal fluid-trigeminal nerve and blood-retina interfaces in the rat by Arakaki, Xianghong et al.
 
Na,K-ATPase alpha isoforms at the blood-cerebrospinal fluid-
trigeminal nerve and blood-retina interfaces in the rat
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Arakaki, Xianghong, Paige McCleary, Matthew Techy, Jiarong
Chiang, Linus Kuo, Alfred N Fonteh, Brian Armstrong, Dan
Levy, and Michael G Harrington. 2013. Na,k-atpase alpha
isoforms at the blood-cerebrospinal fluid-trigeminal nerve and
blood-retina interfaces in the rat. Fluids and Barriers of the CNS
10: 14.
Published Version doi:10.1186/2045-8118-10-14
Accessed February 19, 2015 12:06:00 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11180405
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAARESEARCH Open Access
Na,K-ATPase alpha isoforms at the blood-
cerebrospinal fluid-trigeminal nerve and blood-
retina interfaces in the rat
Xianghong Arakaki
1, Paige McCleary
1, Matthew Techy
1, Jiarong Chiang
1, Linus Kuo
1, Alfred N Fonteh
1,
Brian Armstrong
2, Dan Levy
3 and Michael G Harrington
1*
Abstract
Background: Cerebrospinal fluid (CSF) sodium concentration increases during migraine attacks, and both CSF and
vitreous humor sodium increase in the rat migraine model. The Na,K-ATPase is a probable source of these sodium
fluxes. Since Na,K-ATPase isoforms have different locations and physiological roles, our objective was to establish
which alpha isoforms are present at sites where sodium homeostasis is disrupted.
Methods: Specific Na,K-ATPase alpha isoforms were identified in rat tissues by immunohistochemistry at the blood-CSF
barrier at the choroid plexus, at the blood-CSF-trigeminal barrier at the meninges, at the blood-retina barrier, and at the
blood-aqueous barrier at the ciliary body. Calcitonin gene-related peptide (CGRP), occludin, or von Willibrand factor
(vWF) were co-localized with Na,K-ATPase to identify trigeminal nociceptor fibers, tight junctions, and capillary
endothelial cells respectively.
Results: The Na,K-ATPase alpha-2 isoform is located on capillaries and intensely at nociceptive trigeminal nerve fibers at
the meningeal blood-CSF-trigeminal barrier. Alpha-1 and −3 are lightly expressed on the trigeminal nerve fibers but not
at capillaries. Alpha-2 is expressed at the blood-retina barriers and, with alpha-1, at the ciliary body blood aqueous
barrier. Intense apical membrane alpha-1 was associated with moderate cytoplasmic alpha-2 expression at the choroid
plexus blood-CSF barrier.
Conclusion: Na,K-ATPase alpha isoforms are present at the meningeal, choroid plexus, and retinal barriers. Alpha-2
predominates at the capillary endothelial cells in the meninges and retinal ganglion cell layer.
Keywords: Cerebrospinal fluid (CSF), Choroid plexus (CP), Meninges, Retina
Background
Sodium is crucial for neuronal excitability: when the mem-
brane potential of a neuron depolarizes, sodium channels
open. When the potential reaches a threshold, the sodium
current becomes regenerative and initiates the action po-
tential. Hodgkin and Katz showed that altered extracellular
sodium concentration changes the action potential ampli-
tude in squid axon [1,2]. Recent experiments revealed that
sodium increases in human lumbar CSF by 3 – 4m Md u r -
ing migraine attacks [3], and in the intracranial CSF and
ocular vitreous humor by over 20 mM in a rat model of
central sensitization [4]. Since retinal ganglion cells partici-
pate in the photophobia of migraine [5], this intraocular
increase of sodium may implicate a local retinal stimula-
tion from elevated sodium concentrations. The degree of
these sodium changes are sufficient to increase neuronal
excitability by more than 1.75 fold in simulated [4] and
primary cultured neurons [6]. Stimulation of trigeminal
meningeal nociceptors and retinal neurons might contrib-
ute to the cranial pain and light sensitivity of migraine [7].
The enzyme Na,K-ATPase is a potential source to change
[Na
+], and the expression of Na,K-ATPase alpha isoforms
in the related barriers will be reported in this study.
Cerebrospinal fluid (CSF) cations are tightly regulated
at distinctly different concentrations than in blood, with
higher sodium and lower potassium in CSF, made possible
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rection of the gradient. Choroid plexuses (CP) in the lat-
eral, third, and fourth ventricles generate most of the CSF,
including these cation gradients. These CP vascular struc-
tures have fenestrated capillaries from which the blood ex-
udes to face the basal wall of a single layer of epithelial
cells. Tight junctions between these epithelial cells [9] pro-
hibit diffusion from this exudate directly into CSF, and
vice versa. The Na,K-ATPase alpha-1 isoform at the apical
membrane of these cells [10,11], together with other
transporters [12-14] including the Na
+-K
+-2Cl
- cotrans-
porter and the Na
+-H
+ exchanger, is critical for the Na
+
secretion and K
+ absorption from CSF that result in this
characteristic CSF-blood cation gradient. We, therefore,
studied the Na,K-ATPase isoforms at the CP.
Once released from the CP, CSF is in direct contact
with capillaries extensively throughout the meninges.
Capillaries in the dura, arachnoid, and pia mater have
tight junctions [9] in place of their normal fenestrations,
although some meningeal vessels have been reported to
be fenestrated [15]. Meningeal capillaries, however, have
not been as extensively studied as those at the blood–
brain capillary interface, where it is clear that surround-
ing pericytes, astrocyte endfeet, and neuronal processes
bolster the endothelial cell tight junctions at the blood–
brain barrier [9]. In addition, peripheral sensory nerves
have tight junctions between intraneural capillary endo-
thelial cells and the perineurium, forming a blood-nerve-
barrier [16], though these have not yet been studied in the
meningeal nerves. We define the barrier in meningeal
blood vessels between blood and CSF and the barrier in
meningeal nerve fibers between nerve and blood/CSF to-
gether as the blood-CSF-trigeminal barrier.
The blood supply for the retina includes the intraretinal
vessels for the inner 2/3 and choroidal vessels for the
outer 1/3. There are two blood-retina barriers: tight junc-
tions between the inner intraretinal capillary endothelial
cells at the retinal ganglion cell layer protect the inner 2/3
of the retina, and tight junctions between the retinal pig-
ment epithelial (RPE) cells form the barrier to the outer,
fenestrated choroidal blood supply [17-19]. A third barrier
in the eye, the blood-aqueous barrier, is formed by the
tight junctions in the non-pigmented epithelium (NPE) of
the ciliary body [20], where the Na,K-ATPase contributes
to sodium and aqueous humor secretion [21].
How sodium dysregulation arises in the migraine model
is not defined, and prompted the anatomical studies re-
ported in this paper. Altered Na,K-ATPase activity is con-
sidered primarily responsible for the sodium changes
found in CSF [7]. The 3 alpha isoforms of Na,K-ATPase in
brain have different distributions and activities related to
their varied functions, and yet they have not been com-
pletely characterized at these blood-fluid barriers. To gain
further definition of the Na,K-ATPase isoforms at these
barriers, we localize the Na,K-ATPase alpha −1, -2, and −3
isoform expression at the principal source of CSF (in the
CP), at the sites of intracranial trigeminal nociception (in
the meninges), and at the sites of ocular sodium regulation
(in the ciliary body and retina).
Methods
Fourty-three Sprague–Dawley male rats (Harlan) between
the weights of 180 and 240 g were used in these studies.
The HMRI Animal Care and Use Committee approved
animal procedures.
Tissue preparation
For the retina, ciliary body, and CP studies, rats were
deeply anesthetized with pentobarbital (50–100 mg/Kg).
After euthanasia by decapitation, eyes were enucleated
and brains were removed. Brain regions were identified
with reference to the Paxinos and Watson brain atlas
[22]. Coronal sections were cut from eyes and brains,
frozen in O.C.T. compound (Tissue Tek, Torrance, CA)
in tissue blocks (Pathology Innovations, Wyckoff, NJ),
and sliced into 12 μm sections using a cryostat (Mikron,
Vista, CA). Each section was mounted on Fisherbrand
Superfrost
W Plus precleaned slides (Fisher Scientific,
Pittsburgh, PA) and stored at −30°C until stained. These
tissues were fresh-frozen without cryoprotection, and
ethanol fixed on their slide at the start of immunostain-
ing. For meningeal studies, rats were deeply anesthetized
with pentobarbital, then transcardially perfused with
PBS followed by fresh 2% paraformaldehyde. The dura
with meninges were carefully stripped from the inner
calvarium, cut around the base of the brain and removed
in one piece from its surface. The meninges over the
cerebellum were removed; the remainder cut into half,
stained as floating sections, and then mounted on slides.
This preparation was predominantly dura, but we refer
to it as meninges as it also includes significant arachnoid
and possibly some pial fragments.
Antibodies
The following antibodies were used in this study: mouse
monoclonal anti-Na,K-ATPase alpha-1 (Cat# 05–369,
Millipore); rabbit anti-Na,K-ATPase alpha-2 (Cat# 07–
674, Millipore); rabbit anti-Na,K-ATPase alpha-3 (Cat#:
06–172, Millipore); mouse monoclonal anti-vWF (Cat# LS-
B4034, Lifespan Biosciences); rabbit anti-vWF (Cat#: ECM
590, Millipore); guinea pig anti-CGRP (Cat#: T-5027, Pen-
insula Laboratories, LLC); rabbit anti-occludin (Cat#: sc-
5562, Santa Cruz Biotechnology); goat anti-guinea pig IgG
(Cat#: BA-7000, Vector Laboratories); goat anti-rabbit IgG
(Cat# BA-1000; Vector Laboratories); horse anti-mouse rat
adsorbed IgG (Cat# BA-2001, Vector Laboratories). The
following combinations were used in fluorescence experi-
ments: For Figure 1, guinea pig anti-CGRP primary
Arakaki et al. Fluids and Barriers of the CNS 2013, 10:14 Page 2 of 11
http://www.fluidsbarrierscns.com/content/10/1/14antibody, goat anti-guinea pig IgG secondary antibody,
with fluorescein; followed by rabbit anti-Na,K-ATPase
alpha-2 primary antibody (1:500), goat anti-rabbit IgG
secondary antibody, with Texas red. For Figure 2, guinea
pig anti-CGRP primary antibody, goat anti-guinea pig IgG
secondary antibody, with Texas red; followed by mouse
anti-Na,K-ATPase alpha-1 primary antibody, horse anti-
mouse rat adsorbed IgG secondary antibody, with fluores-
cein. For Figure 3, rabbit anti-Na,K-ATPase alpha-2
primary antibody, goat anti-rabbit IgG secondary anti-
body, with fluorescein; followed by mouse anti-Na,
K-ATPase alpha-1 primary antibody, horse anti-mouse rat
adsorbed IgG secondary antibody, with Texas red. For
Figures 4 and 5, mouse anti-Na,K-ATPase alpha-1, or
rabbit anti-Na,K-ATPase alpha-2, or rabbit anti-Na,
K-ATPase alpha-3 primary antibody, horse anti-mouse
rat adsorbed IgG (for alpha-1) or goat anti-rabbit IgG
(for alpha-2 and alpha-3) secondary antibody, with
fluorescein; followed by rabbit anti-vWF (for alpha-1) or
mouse anti-vWF (for alpha-2 and alpha-3) primary anti-
body, goat anti-rabbit IgG (for alpha-1) or horse anti-
mouse (for alpha-2 and alpha-3) IgG secondary anti-
body, with Texas red. To reduce background, all wash
solutions contained 2% normal serum from the host of
the secondary antibody. Since the dura is around 50
μm thick and tends to have high background, all dura
rinses between treatments were 4 times15 min.
The aforementioned Na,K-ATPase alpha-2 antibody
we used was imperfect for retinal layer staining in
comparison to the published work [23], but we demon-
strate its specificity on retinal capillaries in the retinal
ganglion cell layer and CP.
Immunohistochemistry
Meninges, CPs from the lateral and 3rd ventricles, and
eyes were labeled with antibodies specific for the Na,K-
ATPase alpha-1, alpha-2, and alpha-3 isoforms (1:1,000
unless otherwise stated, Millipore, Billerica, MA), von
Willebrand factor (vWF) (1:500 dilution from Millipore
or 1:100 dilution from Lifespan Biosciences, Seattle,
WA), calcitonin gene-related peptide (CGRP) (1:5000 in
Figure 2, 1:1,000 dilution in all other occasions, Penin-
sula Laboratories, LLC, San Carlos, CA), and occludin
(1:200 dilution from Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA). Species-specific, biotinylated secondary
antibodies were optimized at 1:200 or 1:500. Negative
control procedures included identical steps, but without
primary antibody. Pre-absorption of the alpha-2-anti-
serum with peptide in molar excess abrogated specific
immunoreactive alpha-2 at the CP epithelium, the retinal
ganglion cell layer, and the retinal pigment epithelium.
Diaminobenzidine tetrahydrochloride (DAB) staining:
after washing out the fixative with phosphate-buffered
saline containing 0.5% Triton X-100 (PBST), meninges
were incubated in avidin for 15 min, rinsed with PBST,
biotin blocking solution (Vector Laboratories, Burlin-
game, CA) for 15 min, followed by 1–2 h in a solution
of 5% normal serum (from same species as the host of
the secondary antibody) and 0.3% H2O2 in PBST. Slices
were incubated in primary antibody (alpha-1, alpha-2,
alpha-3, CGRP, occludin, and vWF) or peptide pre-
absorbed alpha-2 antibody with 2% normal serum in
PBST at 4°C overnight, washed in PBS, incubated for 2 h
at room temperature with biotinylated secondary anti-
body with 2% normal goat serum in PBS, washed in
Figure 1 Fluorescence images of CGRP and Na,K-ATPase alpha-2 in meninges. In the top row, CGRP is labeled with fluorescein on
the left, Na,K-ATPase alpha-2 is visualized with Texas red, nuclei are DAPI-stained, and the merged image is on the right. The large
arrow indicates a capillary and the smaller arrowhead indicates a trigeminal nerve. The lower row images are negative controls when
no primary antibody was used. The notable finding is that Na,K-ATPase alpha-2 is expressed at the capillary and nerve fiber. Scale
bar= 10 μm.
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fluorescein in the left, CGRP is visualized with Texas red, nuclei are DAPI-stained, and the merged image is on the right. The large arrow indicates
a capillary and the arrowhead triplet indicate a trigeminal nerve. The lower horizontal images are negative controls when no primary antibody
was used. The notable finding is that Na,K-ATPase alpha-3 is expressed at the nerve fiber, not on the capillary. Scale bar= 10 μm.
Figure 3 Representative immunofluorescence images of a choroid plexus from the 3rd ventricle, sequentially acquired at 1 μm steps
in a z-stack to reveal the cellular location of Na,K-ATPase alpha-1 and −2 isoforms. The same Na,K-ATPase expression patterns were found
in the choroid plexuses in the lateral ventricles (data not shown). Texas red is used to visualize alpha-1 and fluorescein for alpha-2, and the nuclei
are DAPI stained. Negative controls (without primary antibody; data not shown) had no membrane or cytoplasmic staining. Scale bar= 10 μm.
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laboratories) for 30 min, washed in PBS, incubated in
DAB (Invitrogen Life Technologies, Grand Island, NY) so-
lution for 5–10 min, and rinsed in PBS to terminate the
reaction. The edges of meninges were scored to flatten
their curve and mounted on glass slides. After drying over-
night, meninges were dehydrated with ethanol (70, 95, 100,
100%; 10 min each step), xylene for 10 min, and covered in
mounting medium (Thermo Scientific) with cover slides.
Fluorescence double labeling: Eyes and brain slides were
fixed in 100% ethanol for 2 h. Fixed tissues on slides or
freshly prepared, floating meninges were stained using the
aforementioned procedure but replacing the ABC complex
with 30 min to 1 h incubation in Fluorescein Avidin DCS,
or Texas Red Avidin D (Vector Laboratories). This and all
subsequent procedures were carried out in the dark. After
PBST washes, the same process was repeated for the sec-
ond antibody and the opposite fluorophore from that used
for the first antibody. The slices were rinsed in PBS,
mounted with ProLong Gold antifade reagent with 4’ ,6 -
diamidino-2-phenylindole (DAPI) (Invitrogen, Sunnyvale,
CA), a cover slide was attached and sealed with clear
fingernail polish. Preparations were cured in darkness,
usually for>24 h.
DAB-stained sections were imaged on a Nikon eclipse
TS100 microscope. Large tiled images (up to 8x8 tiles,
See Figures 1 & 6) were acquired on a Zeiss Observer
Z1 microscope (Carl Zeiss, Jena, Germany), 5x/0.5NA ob-
jective, Zeiss AxioCamMrC5 color camera, and AxioVision
software v.4.8. Fluorescence images were captured on a
Zeiss LSM 510 NLO microscope (Carl Zeiss, Jena,
Germany) using a 20x/0.8 or 63x/1.4 lens. Samples were
illuminated with Argon/ion (488nm), HeNe (543nm), and
Chameleon Ultra 2-photon (790nm) lasers. Subtraction of
paired images (Figures 7 & 8) was achieved using MIPAV
(http://mipav.cit.nih.gov, Version 12.5).
Figure 4 Representative immunofluorescence images of the blood-aqueous barrier at the rat ciliary body with Na,K-ATPase alpha-1, -2,
and −3 isoform expression. Na,K-ATPase isoforms labeled with fluorescein in left hand column images, vWF visualized with Texas red in second
column, nuclei are DAPI stained, and the merged image for each horizontal panel is in the right hand column. Lower horizontal images are
negative controls with no primary antibody. Merged images show alpha-1 expressed on the PE, alpha-2 on the NPE, and alpha-2 expressed on
ciliary body capillaries. The arrowhead points to the PE on the alpha-1 merged image, and the arrow points to the NPE on the alpha-2 merged
image. Scale bar=20 μm.
Arakaki et al. Fluids and Barriers of the CNS 2013, 10:14 Page 5 of 11
http://www.fluidsbarrierscns.com/content/10/1/14Results
Meninges
We used CGRP with immunoreactivity for trigeminal
meningeal nerve fibers, some of which are on or near
meningeal vessels [24], and because they are altered in mi-
graine [25]. We observed that Na,K-ATPase alpha-2 was
expressed in trigeminal nerve fibers, the transverse and sa-
gittal sinuses, large middle meningeal artery branches
(Figure 9), and capillaries (Figure 9B, Figure 1). The tight
junction protein, occludin, was also expressed on trigemi-
nal meningeal nerve fibers, venous sinuses, MMA
branches, and capillaries (Figure 6), with the same distri-
bution as Na,K-ATPase alpha-2 (Figure 9) and CGRP
(Figure 10). The anti-CGRP stained the nerve fiber, but
not the capillaries in Figure 2, probably because the con-
centration is much lower (1:5,000), and Texas red, a
weaker signal than fluorescein, was used for CGRP in this
experiment. Na,K-ATPase alpha-1 and alpha-3 were
lightly expressed in MMA branches and nerve fibers, but
not at capillaries (Figure 10). Alpha-3 expression was con-
firmed in fluorescence labeling at trigeminal nerve fibers,
but not at capillaries (Figure 2).
Choroid plexus
Na,K-ATPase alpha-1 was intensely expressed along
the apical membrane of the choroidal epithelial cells,
while the alpha-2 was moderately expressed in epithelial
cell cytoplasm. The cellular locations of these isoforms
are distinct on the z-stacked images (Figure 3). Na,K-
ATPase alpha-2 labeling in the CP was abrogated with
peptide pre-absorption (Figure 7), confirming the speci-
ficity of the cytoplasmic alpha-2 immunoreactivity. Na,
Figure 5 Representative immunofluorescence images of Na,K-ATPase alpha-1, -2, and −3 expression at the rat retina. Na,K-ATPase
isoforms labeled with fluorescein in the left hand column images, vWF visualized with Texas red in the second column, nuclei are DAPI-labeled,
and the merged image for each horizontal panel is in the right hand column. Lower horizontal images are negative controls when no primary
antibody was used. Unique Na,K-ATPase alpha-1 & -3 specific expression in the retinal cell layers is seen, similar to previous reports [23,44].
The arrow indicates alpha-2 expression in the capillaries at the retinal ganglion cell layer. GC: ganglion cell layer; IN: inner nuclear layer; ON: outer
nuclear layer are labeled for orientation on the alpha-3 DAPI image. Scale bar=50 μm.
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ependymal cells and in the capillaries of the CP (Figure 7
and data not shown). Na,K-ATPase alpha-3 was not ex-
pressed in the choroid epithelium or in its blood supply
(data not shown).
Ciliary body
The Na,K-ATPase alpha-1 isoform is expressed on the
basolateral surface of the pigmented epithelium (PE),
while alpha-2 is located densely in the basolateral mem-
brane of the NPE on the side facing the aqueous humor.
Figure 7 A is a tiled DAB image, locating occludin at the rat meninges. The field of view is half of the meninges, extending from the TS to
the SSS centrally, the MMA laterally, with the TN crossing the dura. Scale bar 500 μm. B: Enlarged region of meninges, magnified from the
rectangle area in Figure 6A, illustrating branches of the MMA, a TN, and a capillary (DCap). Scale bar=50 μm. For control, see Figure 10.
Figure 6 A is a tiled DAB image of Na,K-ATPase alpha-2 immunostaining at the rat meninges. The field of view is half of the meninges,
extending from the transverse sinus (TS) to the superior sagittal sinus (SSS) centrally and the middle meningeal artery (MMA) laterally, with the
trigeminal nerve fibers (TN) crossing the dura. Scale bar 500 μm. B: Enlarged region of meninges, magnified from the rectangle area in Figure 9A,
illustrating branches of the MMA, a TN, and a capillary (DCap). Scale bar=50 μm. For control, see Figure 10.
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endothelial cell marker, in the ciliary body capillaries.
Alpha-3 was not expressed in the ciliary body epithelium
or in the capillaries (Figure 4).
Retina
Na,K-ATPase alpha-1 and alpha-2 were expressed in the
RPE, but only the alpha-2 isoform co-localized with vWF
on the blood vessel endothelial cells around the retinal
ganglion cells (Figure 5). The alpha-3 isoform did not co-
localize with any blood vessels in the retina. After peptide
pre-absorption, alpha-2 expression in the ganglion cell
layer and RPE disappeared, indicating specificity of alpha-2
immunoreactivity at these locations (Figure 8).
Discussion
We report that the ouabain-sensitive Na,K-ATPase
alpha-2 isoform is located at CP, meningeal, retinal, and
ciliary body barriers, either by itself or with alpha-1, and
the alpha-2 is the consistent capillary endothelial cell
isoform at these blood-barrier locations. The endothelial
cell does not always choose the Na,K-ATPase alpha-2 in
the nervous system; for instance, the alpha-1 is the
endothelial isoform in the labyrinthine barrier [26]. It is
plausible that the specific Na,K-ATPase isoforms at these
locations are important in sodium flux, and thus
contribute to the sodium disturbance of migraine. One
distinction for Na,K-ATPase regulation conferred by
alpha chain isoforms is that alpha-1 is relatively insensitive
to ouabain (Kd around 30 μM), whereas alpha-2 and −3a r e
sensitive with Kd around 15 – 41 nM [27], close to the con-
centration of circulating endogenous ouabain-like com-
pounds [28]. In humans, the Na,K-ATPase Kd for ouabain
appears similar for the three alpha isoforms in studies thus
far, while varying considerably between different cardiac
glycoside compounds [29].
Meninges
The meningeal barrier is created at the tight junctions
between the meningeal vascular endothelial cells, sepa-
rating capillary blood from CSF, and at the trigeminal
nerve barrier. The faint presence of Na,K-ATPase alpha-1
and −3 isoforms in meningeal sensory nerve fibers and
the intense alpha-2 isoform expression in both meningeal
nerve fibers and capillaries indicate an important neu-
rovascular role for Na,K-ATPase alpha-2 in regulating so-
dium at the trigeminal nerves. These results provide the
first evidence that both occludin and alpha-2 Na,K-
ATPase are expressed in the rat meninges, both in blood
vessels and around CGRP-positive, nociceptive nerve fi-
bers. Occludin expression in the nerve fiber is most likely
in the endoneurial capillary endothelial cells and
Figure 8 Representative images of meningeal areas showing DAB-stained Na,K-ATPase alpha-1, alpha-3, CGRP, and control, as
indicated in the sections. M: branch of middle meningeal artery; N: trigeminal nerve fiber; c: capillary. Scale bar =50 μm.
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[16]. Precise localization of Na,K-ATPase alpha-2 and
occludin within the meningeal nerve fiber compartments
will require further study.
Our studies offer anatomical support for Na,K-ATPase
alpha-2 as a modulator of intra-meningeal sodium at the
blood-CSF-trigeminal barrier and, to a lesser extent, for
alpha-1 and −3 at the trigeminal nerve fibers.
Choroid plexus
Consistent with previous studies in the CP [10,11], we
found the alpha-1 subunit is intensely expressed in the
apical membrane of the epithelial cells. The alpha-1 iso-
form has substantially lower affinity (Kd in the μM
range) for the specific Na,K-ATPase inhibitor, ouabain,
than is required to inhibit the alpha-2 and −3N a , K -
ATPase (Kd in the nM range), consistent with the dem-
onstration that 1 mM ouabain is required to retain
sodium in the CP [30]. Using both immunocytochem-
istry and in situ hybridization, CP apical membrane Na,
K-ATPase alpha1 and AQP1 were reported to decrease
with age, thus decreasing CSF secretion in aged rats
[11]. Zlokovic and colleagues reported alpha-1, beta-1,
and beta-2 in the rat CP, but not alpha-2 [31]. Multiple
lines of evidence, therefore, indicate that the apical epi-
thelium Na,K-ATPase alpha-1 is critical for CSF and so-
dium regulation at the choroidal blood-CSF barrier.
The CP barrier, however, may have more complex
regulation of sodium homeostasis, as we found mod-
erate cytoplasmic Na,K-ATPase alpha-2 expression at
choroidal epithelial cells. Since our CP alpha-2 im-
munoreactivity is not consistent with the previous
study [31], we pre-absorbed alpha-2 binding sites
with excess peptide, and the results confirm cyto-
plasmic alpha-2 expression (Figure 7). Furthermore,
we defined the cellular localization of the two alpha
isoforms with 2-photon microscopy (Figure 3). The
difference between our results and previous reports
might arise from different methods: tissue preparation —
previous authors used fixed tissues, while we stained fresh
slices of retina; antibodies — previous authors used poly-
clonal antibodies derived from purified rat brainstem Na,
K-ATPase preparations (no longer available), while we
used synthetic peptide-derived commercial antibodies that
are not as specific immunohistochemically for retinal neu-
rons, but are specific for capillaries; sensitivity — some au-
thors used Western blotting while we used fluorescence
immunostaining.
CSF production and Na,K-ATPase in the CP are reg-
ulated at many levels. Studies have demonstrated that
5-HT or noradrenaline, known migraine triggers, can
reduce CSF production, an activity that was synergis-
tically inhibited by 5-HT and isoproterenol through
PKC, or inhibited through PKA [32]. Cholinergic
agents via the NO/cGMP pathway have been shown to
inhibit CP Na,K-ATPase activity in bovine studies [33].
Thus, modulation of Na,K-ATPase activity is important
for CP functions, and includes pathways known to be
involved in migraine.
The overall regulation by alpha, beta, or gamma subunits
of the CP Na,K-ATPase at the blood-CSF barrier remains
to be elucidated, but we concur with previous studies that
the Na,K-ATPase alpha-1 is the primary regulator of CSF
Figure 9 Specificity of Na,K-ATPase alpha-2 immunoreactivity
at the choroid plexus. The CP was labeled with anti-alpha-2 (A)o r
with peptide pre-absorbed anti-alpha-2 (B). The subtraction image is
in C. D: no primary control. Scale bar=20 μm.
Figure 10 Specificity of Na,K-ATPase alpha-2 immunoreactivity at
the retina. The retina was stained with anti-alpha-2 (A) or with pre-
absorbed anti-alpha-2 (B). Subtraction image is shown in C. D:n o
primary negative control. GC: ganglion cell layer; IN: inner nuclear
layer; ON: outer nuclear layer; asterisk: ganglion cell layer; small
arrow: RPE. Scale bar =20 μm.
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in the CP epithelial cytoplasm merits further study.
Ciliary body
Na,K-ATPase in the ciliary body is modulated by various
factors that affect intraocular pressure and aqueous fluid
[34-36]. Our finding that Na,K-ATPase alpha-2 is ex-
pressed in the endothelial cells of the fenestrated capil-
laries, and very densely in the NPE, while alpha-2 is
expressed in the PE, is consistent with previous work
[21]. Earlier work suggested that the Na,K-ATPase
alpha-1 in PE might control overall sodium secretion,
and alpha-2 in the NPE may be more responsive to en-
vironmental factors [37].
Retina
Our vWF expression data is consistent with the previ-
ously described distribution of intraretinal blood vessels
[38]. The Na,K-ATPase alpha-1, -3 expression we find in
the retina is also consistent with previous reports [23].
The Na,K-ATPase alpha-2 expression (Figure 8), how-
ever, does not match the immunoreactivity shown in the
retinal layers in these earlier studies (with a different anti-
body). Nevertheless, peptide pre-absorption demonstrates
alpha-2 specific expression strongly in the ganglion cell
layer and modestly at the RPE. The Na,K-ATPase expres-
sion in the rat RPE is also consistent with previous light
and electron microscopy, and cell culture studies [39,40],
however, we are cautious about interpreting our modest
RPE specific immunoreactivity: previous immunoblotting
demonstrated alpha-1, beta-1, and beta-2 Na,K-ATPase
subunits from human RPE cells [41], but these authors
found no alpha-2 or −3 RNA transcripts in the human.
Dysregulation of retinal Na,K-ATPase leads to many
pathophysiologies [42,43]. Our findings suggest that the
Na,K-ATPase alpha-2 isoform in the blood-retinal bar-
rier at the retinal ganglion cell layer may play a critical
role in maintaining sodium homeostasis in the retina.
Conclusions
1. Our study provides anatomical evidence of Na,K-
ATPase, mainly the alpha-2 isoform, at the meningeal
trigeminal nerve fibers and capillaries, and at the retinal
ganglion cell layer.
2. At the CP blood-CSF and ciliary body blood-
aqueous barriers, the alpha-1 is the dominant Na,K-
ATPase, though alpha-2 is also present.
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